진료팀소개

[병리과] 배영경교수

이미지 준비중입니다.

진료과
병리과
주연구분야
유전자발현 양상에 따른 유방암의 예후인자
직위
교수
진료과목
유방병리, 피부병리
진료예약
배영경 교수의 진료예약가능 날짜 안내
구분
오전
오후
경력
1993. 03 ~ 1994. 02 영남대학교병원 인턴
1994. 03 ~ 1998. 02 영남대학교병원 병리과 전공의
2003. 03 ~ 2014. 02 영남대학교 의과대학 전임강사, 조교수, 부교수
2014. 03 ~ 현재 영남대학교 의과대학 교수
발표논문 & 컬럼
[학회활동]
대한병리학회, 대한세포병리학회, 한국유방암학회, 대한암학회, 미국캐나다병리학회 정회원
대한병리학회/대한세포병리학회 편집위원
대한세포병리학회 지도의/자격인정위원

[발표논문-주저자]
Impact of immunohistochemistry staining conditions on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer. Kim MC, Kwon SY, Jung HR, Bae YK. Virchows Arch. 2024 Dec;485(6):1117-1125.
A Nationwide Study on HER2-Low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols. Kim MC, Cho EY, Park SY, Lee HJ, Lee JS, Kim JY, Lee HC, Yoo JY, Kim HS, Kim B, Kim WS, Shin N, Maeng YH, Kim HS, Kwon SY, Kim C, Jun SY, Kwon GY, Choi HJ, Lee SM, Choi JE, An AR, Choi HJ, Kim E, Kim A, Kim JY, Shim JY, Gong G, Bae YK. Cancer Res Treat. 2024 Oct;56(4):1096-1104.
Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. Kim MC, Kwon SY, Choi JE, Kang SH, Bae YK. J Breast Cancer. 2023 Apr;26(2):105-116.
Characteristics and Prognosis of Estrogen Receptor Low-Positive Breast Cancer. Kim MC, Park MH, Choi JE, Kang SH,Bae YK. J Breast Cancer. 2022 Aug;25(4):318-326.
Immunohistochemical s of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer. Park MH, Choi JE, Kim JR, Bae YK. Pathol Oncol Res. 2021 Jun 29;27:1609795.
Clinicopathologic features of cutaneous stases from internal malignancies. Kwon HM, Kim GY, Shin DH, Bae YK. J Pathol Transl Med. 2021 Jul;55(4):289-297.
Standardized Pathology Report for Breast Cancer. Cho SY, Park SY, Bae YK, Kim JY, Kim EK, Kim WG, Kwon Y, Lee A, Lee HJ, Lee JS, Park JY, Gong G, Yoon HK. J Breast Cancer. 2021 Feb;24(1):1-21.
Intratumoral CD103-positive Tumor-Infiltrating Lymphocytes Are Associated With Favorable Prognosis in Patients With Triple-Negative Breast Cancer. Park MH, Kwon SY, Choi JE, Gong G, Bae YK. Histopathology. 2020 Oct;77(4):560-569.
High Mobility Group A1 (HMGA1) Protein and Gene Correlate With ER-negativity and Poor Outcomes in Breast Cancer. Gorbounov M, Carleton NM, Asch-Kendrick RJ, Xian L, Rooper L, Chia L, Cimino-Mathews A, Cope L, Meeker A, Stearns V, Veltri RW, Bae YK*, Resar LMS*. (*co-corresponding) Breast Cancer Res Treat. 2020;179(1):25-35.
질병백과

TOP